ArticleCureus2025
A Case of an 80-Year-Old Woman With Chronic Eosinophilic Pneumonia and Clinically Significant Giant Hepatic Hemangioma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An 80-year-old woman with a history of chronic eosinophilic pneumonia (CEP), severe persistent asthma, concomitant severe idiopathic urticaria, fibrous dysplasia of bone, osteoporosis resulting from years of oral corticosteroid usage, and arthralgia, presented to the allergy and immunology clinic with abdominal discomfort. Abdominal and pelvic CT scan showed a hepatic hemangioma, measuring approximately 8.2 x 6.4 cm. The patient underwent arterial embolization with no improvement in size or symptoms. CT scan of the same area taken eight years later had the same large, well-defined hypodense lesion in the right hepatic lobe that increased in size to 10.5 x 7.3 cm. The larger hemangioma now resulted in a mass effect on the upper pole of the right kidney, encroaching on the second portion of the duodenum, and pushing the vertebral column to the left. The patient's CEP was well controlled after desensitization to reslizumab, which initially induced urticaria. Her asthma symptoms are well controlled with reslizumab. Our patient demonstrates that, even in older age groups, it is still possible to present with mega hepatic hemangiomas, despite the median age of presentation being 46. Patients who experience abdominal symptoms, increased hemangioma size, and anxiety frequently undergo surgical resection. Our patient also met the criteria for a resection. The patient was referred to the University of Pittsburgh for excision. However, despite her CEP and asthma under control, following the principle of primum non nocere (first, do no harm), no treatment was advised, opting for close observation. While larger hemangiomas have been reported, this case demonstrates that even in the elderly, with multiple co-morbidities, one may tolerate a growing mega hepatic hemangioma. Age and comorbidity may preclude operative therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.